{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464375437
| IUPAC_name = 5-[(3''S'',8''R'',9''S'',10''R'',13''R'',14''S'',17''R'')-14-Hydroxy- 10,13-dimethyl-3-((2''R'',3''R'',4''R'',5''R'',6''R'')-3,4,5-trihydroxy- 6-methyltetrahydro-2''H''-pyran-2-yloxy)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro- 1''H''-cyclopenta[''a'']phenanthren-17-yl]-2''H''-pyran-2-one
| image = Proscillaridin structure.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|proscillaridin}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 466-06-8
| ATC_prefix = C01
| ATC_suffix = AB01
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 600325
| PubChem = 5284613
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4447658
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = KC6BL281EN
| synonyms = 3β-Rhamnosido-14β-hydroxybufa-4,20,22-trienolide

<!--Chemical data-->
| C=30 | H=42 | O=8 
| molecular_weight = 530.650
| smiles = O=C\1O\C=C(/C=C/1)[C@H]2CC[C@@]6(O)[C@]2(C)CC[C@H]5[C@H]6CC/C4=C/[C@@H](O[C@@H]3O[C@H]([C@H](O)[C@@H](O)[C@H]3O)C)CC[C@@]45C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C30H42O8/c1-16-24(32)25(33)26(34)27(37-16)38-19-8-11-28(2)18(14-19)5-6-22-21(28)9-12-29(3)20(10-13-30(22,29)35)17-4-7-23(31)36-15-17/h4,7,14-16,19-22,24-27,32-35H,5-6,8-13H2,1-3H3/t16-,19-,20+,21-,22+,24-,25+,26+,27-,28-,29+,30-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MYEJFUXQJGHEQK-ALRJYLEOSA-N
}}

'''Proscillaridin''' is a [[cardiac glycoside]], a kind of drug that can be used in the treatment of [[congestive heart failure]] and [[cardiac arrhythmia]] (irregular heartbeat). It is of the [[bufanolide]] type and can be obtained from plants of the genus ''[[Scilla]]'' and in ''[[Drimia maritima]]'' (''Scilla maritima'').<ref>{{Cite journal | last1 = Kedra | first1 = M. | last2 = Kedrowa | first2 = S. | title = Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima | journal = Polski tygodnik lekarski (Warsaw, Poland : 1960) | volume = 23 | issue = 19 | pages = 714–716 | year = 1968 | pmid = 4876207}}</ref>

The [[aglycone]] of proscillaridin is [[scillarenin]].

==References==
{{reflist}}

{{Cardiac glycosides}}

[[Category:Rhamnosides]]
[[Category:Bufanolides]]


{{cardiovascular-drug-stub}}